Articles publicats

Articles publicats 1 registres trobats  La cerca s'ha fet en 0.01 segons. 
1.
15 p, 3.0 MB Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL / Rejeski, Kai (Bavarian Cancer Research Center (Alemanya)) ; Blumenberg, Viktoria (Bavarian Cancer Research Center (Alemanya)) ; Iacoboni, Gloria (Vall d'Hebron Institut d'Oncologia) ; López Corral, Lucia (Centro de Investigación del Cáncer-IBMCC (Espanya)) ; Kharboutli, Soraya (University Hospital Erlangen (Alemanya)) ; Hernani, Rafael (Hospital Clínico Universitario (Espanya)) ; Petrera, Agnese (German Research Center for Environmental Health (Alemanya)) ; Müller, Niklas (University Hospital (Alemanya)) ; Hildebrand, Friederike (University Hospital (Alemanya)) ; Frölich, Lisa (German Cancer Consortium (Alemanya)) ; Karschnia, Philipp (University Hospital (Alemanya)) ; Schmidt, Christian (University Hospital (Alemanya)) ; Cordas dos Santos, David M. (German Cancer Consortium (Alemanya)) ; Piñana, José Luis (Hospital Clínic Universitari (València)) ; Müller, Fabian (University Hospital Erlangen (Alemanya)) ; Martin, Ana Africa (Centro de Investigación del Cáncer-IBMCC (Espanya)) ; Dreyling, Martin (University Hospital (Alemanya)) ; von Bergwelt-Baildon, Michael (Bavarian Cancer Research Center (Alemanya)) ; Barba, Pere (Vall d'Hebron Institut d'Oncologia) ; Subklewe, Marion (Bavarian Cancer Research Center (Alemanya)) ; Bücklein, Veit (Bavarian Cancer Research Center (Alemanya)) ; Universitat Autònoma de Barcelona
Early fever after chimeric antigen receptor T-cell (CAR-T) therapy can reflect both an infection or cytokine release syndrome (CRS). Identifying early infections in the setting of CRS and neutropenia represents an unresolved clinical challenge. [...]
2023 - 10.1097/HS9.0000000000000858
HemaSphere, Vol. 7 (april 2023)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.